Ginger Graham of Harvard Business School and past president of Amylin Pharmaceuticals
The CEO’s Role: Standing in the Narrowing of the Hour Glass
Ginger Graham has been in your shoes: a CEO of both a privately held and a publicly held corporation. She consults to CEO’s of companies big and small; in profit, non-profit and academic organizations; for those newly in the job and the more-experienced. And, as a faculty member at the Harvard Business School, she joined her colleague, Noam Wasserman, in teaching a course called “The Founder’s Dilemmas.” The course is based on a decade of research looking at common pitfalls founders face such as founding with friends and family, how and when to split equity and how to recognize when a successful founder-CEO should exit. Ginger understands and appreciates the many pressures present when running a young company.
Ginger’s career experience includes working in big-pharma, medical devices and bio-tech. She led numerous financings and acquisitions, business integrations and splits, strategic turn-arounds and divestitures. She’s taken a company public, been both bought and sold, and has been on a number of private and public company boards. She’s learned that first-time CEO’s face many common issues and believes in the benefit of building one’s own network of supporters and advisors.
Former CNBC bioscience reporter
Senior Vice President, Director of Media Strategy, MSL New York
The Art of Telling Your Science Story: How to Reach and Resonate from the Rockies
Former CNBC biopharma and medical device industry reporter-turned-PR pro, Mike Huckman, will discuss the good, the bad and the ugly from his decade with a front-row seat to the sectors' ups and downs and the insight they provide for today's life science leaders. And, now, from his position on the other side, what are best practices for communicating good news and bad news in a world of media upheaval and where information travels at hyperspeed? You'll get a key insider's view from the inside and out.